Changes in Bone Mineral Density in the Year After Critical Illness
Overview
Authors
Affiliations
Rationale: Critical illness may be associated with increased bone turnover and loss of bone mineral density (BMD). Prospective evidence describing long-term changes in BMD after critical illness is needed to further define this relationship.
Objectives: To measure the change in BMD and bone turnover markers (BTMs) in subjects 1 year after critical illness compared with population-based control subjects.
Methods: We studied adult patients admitted to a tertiary intensive care unit (ICU) who required mechanical ventilation for at least 24 hours. We measured clinical characteristics, BTMs, and BMD during admission and 1 year after ICU discharge. We compared change in BMD to age- and sex-matched control subjects from the Geelong Osteoporosis Study.
Measurements And Main Results: Sixty-six patients completed BMD testing. BMD decreased significantly in the year after critical illness at both femoral neck and anterior-posterior spine sites. The annual decrease was significantly greater in the ICU cohort compared with matched control subjects (anterior-posterior spine, -1.59%; 95% confidence interval, -2.18 to -1.01; P < 0.001; femoral neck, -1.20%; 95% confidence interval, -1.69 to -0.70; P < 0.001). There was a significant increase in 10-year fracture risk for major fractures (4.85 ± 5.25 vs. 5.50 ± 5.52; P < 0.001) and hip fractures (1.57 ± 2.40 vs. 1.79 ± 2.69; P = 0.001). The pattern of bone resorption markers was consistent with accelerated bone turnover.
Conclusions: Critically ill individuals experience a significantly greater decrease in BMD in the year after admission compared with population-based control subjects. Their bone turnover biomarker pattern is consistent with an increased rate of bone loss.
du Fosse N, Grootjans W, Navas A, Appelman-Dijkstra N, Elzo Kraemer C, van Westerloo D Sci Rep. 2024; 14(1):18359.
PMID: 39112689 PMC: 11306341. DOI: 10.1038/s41598-024-69397-1.
Orford N, Bone A, Kotowicz M, Bailey M, Pasco J, Maiden M Sci Rep. 2024; 14(1):2071.
PMID: 38267490 PMC: 10810087. DOI: 10.1038/s41598-024-52607-1.
Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness.
Kim T, Kim H Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139844 PMC: 10747168. DOI: 10.3390/ph16121718.
Gunst J, Casaer M, Preiser J, Reignier J, Van den Berghe G Crit Care. 2023; 27(1):43.
PMID: 36707883 PMC: 9883882. DOI: 10.1186/s13054-023-04317-9.
de Jonge E, van der Vooren M, Gillis J, Del Prado M, Wigbers J, Bakhshi-Raiez F J Nephrol. 2022; 36(4):1019-1026.
PMID: 36342643 PMC: 10227114. DOI: 10.1007/s40620-022-01482-y.